SOLEIMA MANTILLA: Open Payments
NPI 1669183463 · MANSFIELD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,859 in 55 payments from 20 companies in 2025. Trend: 2023 $84 · 2024 $921 · 2025 $1,859
Food & beverage: $1,629Education: $229
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $201 |
| Daiichi Sankyo Inc. | 5 | $177 |
| SEAGEN INC. | 2 | $175 |
| Genmab U.S., Inc. | 11 | $164 |
| Janssen Biotech, Inc. | 5 | $155 |
| ABBVIE INC. | 2 | $155 |
| Novartis Pharmaceuticals Corporation | 5 | $146 |
| GlaxoSmithKline, LLC. | 2 | $130 |
| Amgen Inc. | 1 | $123 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $95 |
Products named: Enhertu, Tivdak, ELAHERE, JEMPERLI, RYBREVANT, VECTIBIX, Nubeqa, KISQALI.
Industry payments across TX — which companies pay providers there.
